stockrow
Monday 9 November 2026
Export CUVL’s income statement to Excel — free account
Clinuvel Pharmaceuticals Ltd. - Sponsored ADR
CUVL
5.10
0.08
+1.59%
Follow CUVL
Alert me
Clinuvel Pharmaceuticals Ltd. - Sponsored ADR (CUVL) Return on invested capital
Return on invested capital, annual
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| ARCT Arcturus Therapeutics Holdings Inc. compare | 0.00% |
| LRMR Larimar Therapeutics, Inc. compare | 0.00% |
| QTTB Q32 Bio Inc. compare | 0.00% |
| SPRY ARS Pharmaceuticals, Inc. compare | 0.00% |
| SABS SAB Biotherapeutics, Inc. compare | −39.0% |
| RCKT Rocket Pharmaceuticals, Inc. compare | −114.7% |
| LCTX Lineage Cell Therapeutics, Inc. compare | −186.8% |
| LXEO Lexeo Therapeutics, Inc. compare | −253.5% |
| CUVL Clinuvel Pharmaceuticals Ltd. - Sponsored ADR | — |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)